| Institution: | 1. Department of Soft Tissue, Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, Warsaw 02-781, Poland;2. Department of Surgical Oncology, University Hospitals Gasthuisberg Leuven, Herestraat 49, Leuven 3000, Belgium;1. Sheikh Ahmed Pancreatic Cancer Research Center, UT MD Anderson Cancer Center, Houston, TX 77030, USA;2. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA;3. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA;4. Department of Pathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Boulevard, Room Z3.3038, Houston, TX 77030, USA;1. Division of Radiation Oncology, University of South Alabama Mitchell Cancer Institute, 1660 Spring Hill Avenue, Mobile, AL 36604, USA;2. Department of Radiation Oncology, Vanderbilt University Medical Center, 2220 Pierce Avenue, Preston Research Building B-1003, Nashville, TN 37232, USA;1. Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA;2. Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA;3. Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA |
